Lee Ainslie’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,967
Closed -$843K 654
2021
Q3
$843K Sell
4,967
-5,304
-52% -$825K 0.01% 358
2021
Q2
$1.62M Buy
10,271
+1,181
+13% +$175K 0.02% 192
2021
Q1
$1.26M Buy
9,090
+5,077
+127% +$818K 0.01% 211
2020
Q4
$703K Buy
+4,013
New +$748K 0.01% 299
2019
Q4
Sell
-14,462
Closed -$1.24M 434
2019
Q3
$1.24M Buy
+14,462
New +$1.06M 0.02% 257

Other funds holding SGEN

Lee Ainslie's SGEN Position: Q4 2021 in Review

Lee Ainslie sold out of Seagen Inc. Common Stock (SGEN) in Q4 2021, closing a stake of 4,967 shares — an estimated $843K sold.

Lee Ainslie first reported a position in SGEN in Q3 2019 and held it in 5 quarters. The position peaked at $1.62M in Q2 2021. 526 funds tracked by Wall St. Rank hold SGEN as of Q4 2021.

  • Lee Ainslie reported no remaining Seagen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Lee Ainslie sold 4,967 Seagen Inc. Common Stock shares in Q4 2021, an estimated $843K.
  • Lee Ainslie first reported a position in Seagen Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Lee Ainslie's Seagen Inc. Common Stock position peaked at $1.62M in Q2 2021.
  • 526 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.